Federal contract award

36C24822P1535

QIAGEN REAGENTS

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Veterans Affairs
Office248-NETWORK CONTRACT OFFICE 8 (36C248)
NAICS325413 — In-Vitro Diagnostic Substance Manufacturing
PSC6640 — Laboratory Equipment and Supplies
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$454.5K
Current contract value$454.5K
Potential contract value / ceiling$599.2K
Start dateJul 29, 2022
Current end dateSep 30, 2026
Potential end dateSep 30, 2026
Latest award activityAug 10, 2026
Source loadedSep 19, 2026

Funding and modification history

Showing the latest 15 of 15 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Aug 10, 2026P00014$15.0KDE-OBLIGATE EXCESS FUNDS
Jun 9, 2026P00013$-232DE-OBLIGATE EXCESS FUNDS
Apr 15, 2026P00012$-51.0KDE-OBLIGATE EXCESS FUNDS
Oct 1, 2025P00011$144.7KEXERCISE OPTION YEAR 3
Dec 13, 2024P00010$-112EXERCISE OPTION YEAR 3
Oct 1, 2024P00009$144.5KEXERCISE OPTION YEAR 3
Aug 8, 2024P00008$3.9KEXERCISE OPTION YEAR 1, FUNDED
Dec 15, 2023P00007$-190EXERCISE OPTION YEAR 1, FUNDED
Oct 11, 2023P00006$0EXERCISE OPTION YEAR 1, FUNDED
Oct 5, 2023P00005$97.7KEXERCISE OPTION YEAR 1, FUNDED
Oct 1, 2023P00004$44.7KEXERCISE OPTION YEAR 1, FUNDED
Mar 27, 2023P00003$-12.8KEXERCISE OPTION YEAR 1, FUNDED
Oct 1, 2022P00002$44.0KEXERCISE OPTION YEAR 1, FUNDED
Sep 22, 2022P00001$0EXERCISE OPTION YEAR 1, SUBJECT TO AVAILABILITY OF FUNDS
Jul 28, 20220$24.4KQIAGEN REAGENTS

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.